Efficacy and Safety of Xinglou Chengqi Granule for Acute Ischemic Stroke
NCT07163702
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Acute Ischemic Stroke
Interventions
DRUG:
High-dose Xinglou Chengqi granules
DRUG:
Low-dose Xinglou Chengqi granules and placebo
Sponsor
Dongzhimen Hospital, Beijing